Cargando…

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

BACKGROUND: Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis. AIM: The aim of this study was to comprehensively assess th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubin, David T., Sandborn, William J., Bosworth, Brian, Zakko, Salam, Gordon, Glenn L., Sale, Mark E., Rolleri, Robert L., Golden, Pamela L., Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621699/ https://www.ncbi.nlm.nih.gov/pubmed/26386854 http://dx.doi.org/10.1007/s10620-015-3868-5

Ejemplares similares

Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies
por: Bosworth, Brian P., et al.
Publicado: (2016)

Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
por: Christophi, George P, et al.
Publicado: (2016)

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T., et al.
Publicado: (2017)

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T, et al.
Publicado: (2017)

Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
por: Kruis, Wolfgang, et al.
Publicado: (2022)

Ischemic proctosigmoiditis due to retroperitoneal hematoma
por: Roepstorff, Soeren, et al.
Publicado: (2016)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
por: Naganuma, Makoto, et al.
Publicado: (2019)

Expression of Concern: Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
Publicado: (2023)

Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
por: Sandborn, W. J., et al.
Publicado: (2015)

Phlegmonous Proctitis: A Rare Entity of the Presentation of Proctitis
por: Kaewdech, Apichat, et al.
Publicado: (2018)

The value of ICG-guided left colon vascular variation and anatomical rules for the radical resection of proctosigmoid colon cancer
por: Wang, Jiahao, et al.
Publicado: (2023)

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
por: Bajaj, J S, et al.
Publicado: (2015)

Radiation Proctitis: Current Strategies in Management
por: Do, Nhue L., et al.
Publicado: (2011)

Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
por: Shibuya, Tomoyoshi, et al.
Publicado: (2019)

Imaging features of anorectal proctitis in monkeypox infection
por: Messina, Mark D., et al.
Publicado: (2022)

Systematic review for non-surgical interventions for the management of late radiation proctitis
por: Denton, A S, et al.
Publicado: (2002)

Management of radiation-induced proctitis
por: Porouhan, Pejman, et al.
Publicado: (2019)

Radiation Proctitis and Management Strategies
por: Dahiya, Dushyant Singh, et al.
Publicado: (2022)

Chronic radiation proctitis: tricks to prevent and treat
por: Vanneste, Ben G. L., et al.
Publicado: (2015)

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
por: Webster, Lynn R, et al.
Publicado: (2015)

Diclofenac suppositories and acute ischaemic proctitis.
por: Arya, N., et al.
Publicado: (2004)

Sexually transmitted infections manifesting as proctitis
por: Lamb, Chris A, et al.
Publicado: (2013)

Perianal Abscess and Proctitis by Klebsiella pneumoniae
por: Jeong, Woo Shin, et al.
Publicado: (2015)

Secondary Amyloidosis Presenting as Ischemic Proctitis
por: Hashmi, Saad, et al.
Publicado: (2021)

A Curious Case of Severe Proctitis
por: Lopez, Christine R., et al.
Publicado: (2023)

Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration
por: Kuenzig, M Ellen, et al.
Publicado: (2018)

The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study
por: Binicier, Ömer Burcak, et al.
Publicado: (2019)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
por: Travis, Simon P L, et al.
Publicado: (2014)

A rat model for radiation-induced proctitis.
por: Kan, S., et al.
Publicado: (2000)

Ulcerative Proctitis: An Unusual Case of Intestinal Spirochetosis
por: Baum, Jeffrey, et al.
Publicado: (2022)

Severe Mpox Proctitis Complicated by Bowel Obstruction
por: Saleh, Hasan, et al.
Publicado: (2023)

Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis
por: Naganuma, Makoto, et al.
Publicado: (2016)

Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
por: Naganuma, Makoto, et al.
Publicado: (2017)

Formalin Application for the Treatment of Radiation-Induced Hemorrhagic Proctitis
por: Lee, Sun-Il, et al.
Publicado: (2007)

Severe Proctitis Caused by Chlamydia trachomatis Serovars D
por: Fukushima, Kazuaki, et al.
Publicado: (2016)

MRI characteristics of proctitis in Crohn’s disease on perianal MRI
por: Tutein Nolthenius, Charlotte J., et al.
Publicado: (2016)

Herpes Simplex Virus Proctitis Masquerading as Rectal Cancer
por: Ayoade, Folusakin, et al.
Publicado: (2019)

Simple water‐based tacrolimus enemas for refractory proctitis
por: Fehily, Sasha R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rae12rgjjn6bv9kdrgg5uv6nnk